Edward J. Schutter
Independent DirectorMr. Edward J. Schutter, also known as Ed, R. Ph., M.B.A., was Chief Executive Officer of Arbor Pharmaceuticals, LLC from April 2010 to 2021 and serves as its President. Mr. Schutter is the Co-Founder of Med Investor Network Inc. He served as Director of Tidal Vision Products, Inc. He began his pharmaceutical career with Reid-Provident Labs. Mr. Schutter has been a Director of TerrAscend Corp. since November 2, 2020 and served as its Lead Independent Director since March 23, 2021. Mr. Schutter serves as an Executive Director of Med Investor Network Inc. He served as the President and Chief Operating Officer of Shionogi Pharma, Inc. since December 2007. He served as Chief Commercial Officer from April 3, 2006 to August 22, 2008. He served as an Executive Vice President of Sciele Pharma Inc. and a Member of Senior Executive Team since April 3, 2006. Mr. Schutter served in various roles at Sciele Pharma, Inc., a subsidiary of Shionogi & Co., Ltd., including as President and Chief Operating Officer from 2007 to 2009. He served as Vice President, Corporate Development of LivaNova PLC since July 21, 2003. He served as Vice President of Global Business Development and Licensing at Solvay Pharmaceuticals, based in Basel, Switzerland. During his tenure with Solvay, Mr. Schutter served in various commercial roles, including National Sales Director, Marketing Director and Director of Managed Care Sales. He joined Intrance Medical Systems, Inc. and served as Director of The Board since January 2022 until July 2025 and becamed the company’s first U.S.-based Board member. He serves on the boards of Directors of several public and private companies and has been a previous Board Member for several non-profit organizations, including the American Diabetes Association and American Heart Association. Mr. Schutter serves as an Independent Director at Establishment Labs Holdings Inc. since September 2015. Mr. Schutter owned and operated Schutter Pharmacy. Mr. Schutter serves as the Chairman of Georgia Bio. He has been an Independent Director of Vensun Pharmaceuticals, Inc. since April 2015. He has been a Director of Arbor Pharmaceuticals, LLC since April 2010. Mr. Schutter serves as Director at Vitruvias Therapeutics, LLC. He has been a Director of Xenoport, Inc. since July 5, 2016. He is Board of Trustees for Mercer University. He is a Member of the Emory University New Venture Advisory Board. He also served as an Independent Director of Knight Therapeutics Inc. since January 2015 until February 2017. He was a Director of Intrance Medical. Mr. Schutter is a registered pharmacist with a BS degree in Pharmaceutical Sciences from Mercer University, an MBA from Kennesaw State University and has completed graduate studies in International Business at Njienrode University, Amsterdam, Netherlands.
公司职务
- 公司名称Establishment Labs Holdings Inc.股票代码ESTA职务Independent Director共事同僚
- FPFillipo Peter CaldiniCEO & Director
- NSNicholas S. LewinChairman of the Board
- SRS. Ross MansbachGeneral Counsel & Chief Compliance Officer
- CECassandra E. HarrisSenior VP & CFO
- RDRoberto de MezervilleChief Technology Officer
- MWMalavika WilliamVP, Global Head of Marketing & Communications
- AEAnn Esther CustinIndependent Non-Executive Director
- LGLeslie GillinIndependent Director
- 公司名称TerrAscend Corp.股票代码TSNDF职务Director共事同僚
- JGJason Garrett WildExecutive Chairman
- ZGZiad GhanemPresident, CEO & Director
- LGLynn GefenChief People Officer, Chief Legal Officer & Corporate Secretary
- EJEric JacksonChief Financial Officer
- ACAlisa CampbellSVP of Corporate Finance & Accounting
- CACraig Alexander CollardLead Independent Director
- EJEdward J. SchutterDirector
- IDIra DuarteIndependent Director
